咪喹莫特 5%乳膏作为一线治疗药物用于治疗由墨西哥利什曼原虫引起的皮肤利什曼病的疗效。

Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana.

机构信息

Hospital General de México, Servicio de Dermatología, México.

Instituto Mexicano del Seguro Social, Hospital General de Zona 29, Departamento de Medicina Interna, México.

出版信息

Rev Soc Bras Med Trop. 2021 Mar 22;54:e0305-2020. doi: 10.1590/0037-8682-0305-2020. eCollection 2021.

Abstract

Cutaneous leishmaniasis (CL) involves several differential diagnoses as it lacks a gold standard diagnostic test. Its diagnosis is easier in endemic regions; however, many cases come from travelers to endemic areas. A 22-year-old patient, who had recently visited Oaxaca, Mexico, developed two asymptomatic ulcers weeks later on the left auricle and the nose. Leishmania mexicana was identified using polymerase chain reaction. The patient was treated with imiquimod 5% cream three times/week, providing favorable results after 12 weeks, without relapse 2 months after therapy. To our knowledge, this is the first case of CL due to L. mexicana effectively treated with imiquimod.

摘要

皮肤利什曼病(CL)涉及多种鉴别诊断,因为它缺乏金标准诊断测试。在流行地区,其诊断较为容易;然而,许多病例来自前往流行地区的旅行者。一位 22 岁的患者最近访问了墨西哥瓦哈卡州,数周后在左耳和鼻子上出现了两个无症状溃疡。使用聚合酶链反应鉴定出了墨西哥利什曼原虫。患者使用咪喹莫特 5%乳膏每周三次治疗,12 周后结果良好,治疗后 2 个月无复发。据我们所知,这是首例使用咪喹莫特有效治疗的墨西哥利什曼原虫引起的 CL 病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd39/8008850/f0253c0b61ec/1678-9849-rsbmt-54-e0305-2020-gf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索